US approves “new class” of diabetes drug, under review in Canada

Hanna Lange-Chenier

doi:10.1503/cmaj.109-4483

Main menu

Home
Content
Authors & Reviewers
CMA Members
Subscribers
Alerts
- Email alerts
- RSS

CMAJ JOURNALS
- CMAJ Open
- CJS
- JPN

User menu

Subscribe
My alerts
My Cart
Log in

Search

Search for this keyword

Advanced search

CMAJ JOURNALS
- CMAJ Open
- CJS
- JPN

Subscribe
My alerts
My Cart
Log in

Search for this keyword

Advanced Search

Home
Content
Authors & Reviewers
CMA Members
Subscribers
Alerts
- Email alerts
- RSS

Visit CMAJ on Facebook
Follow CMAJ on Twitter
Follow CMAJ on Pinterest
Follow CMAJ on Youtube
Follow CMAJ on Instagram

News

US approves “new class” of diabetes drug, under review in Canada

Hanna Lange-Chenier

CMAJ July 09, 2013 185 (10) E470; DOI: https://doi.org/10.1503/cmaj.109-4483

Hanna Lange-Chenier

CMAJ

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Responses
Metrics
PDF

Article Information

vol. 185 no. 10 E470

DOI

https://doi.org/10.1503/cmaj.109-4483

PubMed

23734031

History

Published online July 8, 2013.

Article Versions

Latest version (June 3, 2013 - 08:38).
You are viewing the most recent version of this article.

Author Information

Hanna Lange-Chenier

CMAJ

Statistics from Altmetric.com

PreviousNext

In this issue

Canadian Medical Association Journal: 185 (10)

CMAJ

Vol. 185, Issue 10

9 Jul 2013

Table of Contents
Index by author

Article tools

Respond to this article

Download PDF

Article Alerts

User Name *

Password *

To sign up for email alerts or to access your current email alerts, enter your email address below:

Email *

Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following US approves “new class” of diabetes drug, under review in Canada

Message Subject (Your Name) has sent you a message from CMAJ

Message Body (Your Name) thought you would like to see the CMAJ web site.

Your Personal Message

Citation Tools

US approves “new class” of diabetes drug, under review in Canada

Hanna Lange-Chenier

CMAJ Jul 2013, 185 (10) E470; DOI: 10.1503/cmaj.109-4483

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Request Permissions

US approves “new class” of diabetes drug, under review in Canada

Hanna Lange-Chenier

CMAJ Jul 2013, 185 (10) E470; DOI: 10.1503/cmaj.109-4483

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Responses
Metrics
PDF

No related articles found.

Scopus
PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Collections

Topics
- Diabetes
- Canadian government

Content

Current issue
Past issues
Collections
Sections
Blog
Podcasts
Videos
Alerts
RSS

Information for

Advertisers
Authors
CMA Members
Media
Reprint requests
Subscribers

About

General Information
Journal staff
Editorial Board
Governance Council
Journal Oversight
Careers
Contact
Copyright and Permissions

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Main menu

User menu

Search

US approves “new class” of diabetes drug, under review in Canada

Article Information

Article Versions

Author Information

Statistics from Altmetric.com

In this issue

Article tools

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Collections

Content

Information for

About